Drug Discovery and Clinical Development (2020)

This MAS is aimed at professionals from academia, the pharmaceutical industry, biotechnology sector, and international organizations who wish to gain an in-depth understanding of drugs and medical devices research and development.

Enable health professionals to gain a strategic vision of clinical development and navigate the complexities of bringing new medicinal products to the global market

Medical doctor, biologist, pharmacist, nurse, biochemist and other professional involved or wishing to gain skills and knowledge, in the field of drug discovery and development

Prof. Jules DESMEULES, Faculty of Medicine, Faculty of Science, University of Geneva and Dr. François CURTIN, GeNeuro

Dr François CURTIN, Faculty of Medicine, University of Geneva, Dr Catherine DELOCHE, Solid Drug Development et Dr Françoise LASCOMBES, External consultant

This programme is accredited by Swissethics, Swiss Association of Pharmaceutical Professionals, Swiss Society of Clinical Pharmacology and Toxicology, Swiss Institute for postgraduate and continuous medical education

Prof. Cem Gabay, Dean of the Faculty of Medicine, University of Geneva
Prof. Arnaud Perrier, Medical Director, University Hospitals of Geneva
Prof. Gerrit Borchard, Head of Biopharmaceutics, Section of Pharmaceutical Sciences, Faculty of Science, University of Geneva
Dr Angèle Gayet-Ageron, CC, Lecturer, Head of the Methodological Support Unit, Clinical Research Centre (CRC), University Hospitals of Geneva, Faculty of Medecine, University of Geneva
Prof. Bernard Hirschel, President, Cantonal Commission on Human Research Ethics, Canton of Geneva
Prof. Samia Hurst, Director, Institute of Ethics, History and Humanities (iEH2), Faculty of Medicine, University of Geneva
Prof. Jérôme Pugin, Vice-Dean of the Faculty of Medicine and President of the Clinical Research Center (CRC), University Hospitals of Geneva, Faculty of Medicine, University of Geneva

Dr Emilie Alirol, Project Leader, Global Antibiotics Research and Development Partnership (GARDP), Drugs for Neglected Diseases initiative (DNDi)
Dr Vanya Beltrami, Vice-President, Head of Manufacturing, Anergis, Lausanne
Dr Jocelyne Chabert, Clinical Research Associate, Clinical Research Centre (CRC), University Hospitals of Geneva, Faculty of Medicine, University of Geneva
Dr Francois Curtin, PD, Medical Director Personalised Health Programmes, Swiss Federal Institute of Technology in Zurich (ETH Zurich) & Lecturer at Hospitals of Geneva (UNIGE)
Dr Patricia Delaite, Medical Director, Geneva
Dr Catherine Deloche, Chief Operating Officer, Solid Drug Development, Geneva
Prof. Philippe Ducor, Faculty of Law, University of Geneva
Prof. Marc Froissart, Chief Medical Director of the Clinical Research (CRC), CHUV-UNIL, Lausanne
Dr Angèle Gayet-Ageron, CC, Lecturer, Head of the Methodological Support Unit, Clinical Research Centre (CRC), University Hospitals of Geneva, Faculty of Medecine, University of Geneva
Dr Françoise Lascombes, External Consultant
Prof. Hervé Porchet, Pharmaceutical consultant
Dr Victoria Rollason, PharmD, Division of Clinical Pharmacology and Toxicology, University Hospitals of Geneva and Faculty of Medicine, University of Geneva
Dr Gabriele Ackermann, Chief Scientific Officer ad interim, Therapeutic Area Head Cardiovascular, Renal & Metabolism Therapeutic Area Head Respiratory, Novartis Pharma Switzerland

Les termes utilisés pour désigner des personnes sont pris au sens générique; ils ont à la fois la valeur d’un masculin et d’un féminin.